Skip to main content
Top
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Research article

Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study

Authors: Hiroshi Nakamura, Tomonori Yano, Satoshi Fujii, Tomohiro Kadota, Toshifumi Tomioka, Takeshi Shinozaki, Ryuichi Hayashi, Kazuhiro Kaneko

Published in: BMC Cancer | Issue 1/2016

Login to get access

Abstract

Background

The incidence rate has been increasing for superficial head and neck squamous cell carcinoma (HNSCC) discovered through surveillance endoscopic study using narrow band imaging (NBI), a procedure mainly used for high-risk patients with esophageal squamous cell carcinoma (ESCC). However, there are few reports on the natural history of superficial HNSCC. The aim of this retrospective study was to investigate the natural history of superficial HNSCC.

Methods

From January 2007 to December 2012, 535 consecutive histologically confirmed superficial HNSCCs at the oropharynx, hypopharynx, or larynx in 319 patients were detected by endoscopic surveillance examination by using NBI. Of those, 20 untreated and observed lesions fulfilled the eligibility criteria and were analyzed in this study.

Results

Twenty lesions from 17 patients were analyzed. All patients were men ranging from 52 to 86 years of age, with a median age of 69 years. The median endoscopic follow-up period was 20 months (range, 6–71); 17 lesions progressed in size. In this study, four patients died; the causes of death were synchronous ESCC, synchronous HNSCC, acute myocardial infarction, and unknown causes. No patient died from progression of superficial HNSCC.

Conclusions

Most superficial HNSCC has the potential to change progressively. Therefore, superficial HNSCC should be detected at an early stage and be treated less invasively, such as with endoscopic resection or partial resection.
Literature
1.
go back to reference Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010;28:9.CrossRef Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010;28:9.CrossRef
2.
go back to reference Katada C, Tanabe S, Koizumi W, Higuchi K, Sasaki T, Azuma M, et al. Narrow band imaging for detecting superficial squamous cell carcinoma of the head and neck in patients with esophageal squamous cell carcinoma. Endoscopy. 2010;42:3.CrossRef Katada C, Tanabe S, Koizumi W, Higuchi K, Sasaki T, Azuma M, et al. Narrow band imaging for detecting superficial squamous cell carcinoma of the head and neck in patients with esophageal squamous cell carcinoma. Endoscopy. 2010;42:3.CrossRef
3.
go back to reference Yagishita A, Fujii S, Yano T, Kaneko K. Endoscopic findings using narrow-band imaging to distinguish between basal cell hyperplasia and carcinoma of the pharynx. Cancer Sci. 2014;105:7.CrossRef Yagishita A, Fujii S, Yano T, Kaneko K. Endoscopic findings using narrow-band imaging to distinguish between basal cell hyperplasia and carcinoma of the pharynx. Cancer Sci. 2014;105:7.CrossRef
4.
go back to reference Muto M, Satake H, Yano T, Minashi K, Hayashi R, Fujii S, et al. Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer. Gastrointest Endosc. 2011;74:3.CrossRef Muto M, Satake H, Yano T, Minashi K, Hayashi R, Fujii S, et al. Long-term outcome of transoral organ-preserving pharyngeal endoscopic resection for superficial pharyngeal cancer. Gastrointest Endosc. 2011;74:3.CrossRef
5.
go back to reference Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc. 2002;56:4.CrossRef Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc. 2002;56:4.CrossRef
6.
go back to reference Muto M, Nakane M, Katada C, Sano Y, Ohtsu A, Esumi H, et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer. 2004;101:6.CrossRef Muto M, Nakane M, Katada C, Sano Y, Ohtsu A, Esumi H, et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer. 2004;101:6.CrossRef
7.
go back to reference Society JE. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6. Society JE. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6.
8.
go back to reference Fujii S, Yamazaki M, Muto M, Ochiai A. Microvascular irregularities are associated with composition of squamous epithelial lesions and correlate with subepithelial invasion of superficial-type pharyngeal squamous cell carcinoma. Histopathology. 2010;56:4.CrossRef Fujii S, Yamazaki M, Muto M, Ochiai A. Microvascular irregularities are associated with composition of squamous epithelial lesions and correlate with subepithelial invasion of superficial-type pharyngeal squamous cell carcinoma. Histopathology. 2010;56:4.CrossRef
9.
go back to reference Takemura K, Doyama H, Nakanishi H, Takeda Y, Kito Y, Ito R, et al. Can flat-type brownish microlesions in the orohypopharynx be followed up without biopsy or endoscopic resection? Dig Endosc. 2014;26:2.CrossRef Takemura K, Doyama H, Nakanishi H, Takeda Y, Kito Y, Ito R, et al. Can flat-type brownish microlesions in the orohypopharynx be followed up without biopsy or endoscopic resection? Dig Endosc. 2014;26:2.CrossRef
10.
go back to reference Satake H, Yano T, Muto M, Minashi K, Yoda Y, Kojima T, et al. Clinical outcome after endoscopic resection for superficial pharyngeal squamous cell carcinoma invading the subepithelial layer. Endoscopy. 2015;47:1. Satake H, Yano T, Muto M, Minashi K, Yoda Y, Kojima T, et al. Clinical outcome after endoscopic resection for superficial pharyngeal squamous cell carcinoma invading the subepithelial layer. Endoscopy. 2015;47:1.
11.
go back to reference Tateya I, Morita S, Muto M, Miyamoto S, Hayashi T, Funakoshi M, et al. Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope. 2014;125:5. Tateya I, Morita S, Muto M, Miyamoto S, Hayashi T, Funakoshi M, et al. Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope. 2014;125:5.
12.
go back to reference Taniguchi M, Watanabe A, Tsujie H, Tomiyama T, Fujita M, Hosokawa M, et al. Predictors of cervical lymph node involvement in patients with pharyngeal carcinoma undergoing endoscopic mucosal resection. Auris Nasus Larynx. 2011;38:6.CrossRef Taniguchi M, Watanabe A, Tsujie H, Tomiyama T, Fujita M, Hosokawa M, et al. Predictors of cervical lymph node involvement in patients with pharyngeal carcinoma undergoing endoscopic mucosal resection. Auris Nasus Larynx. 2011;38:6.CrossRef
Metadata
Title
Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study
Authors
Hiroshi Nakamura
Tomonori Yano
Satoshi Fujii
Tomohiro Kadota
Toshifumi Tomioka
Takeshi Shinozaki
Ryuichi Hayashi
Kazuhiro Kaneko
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2787-y

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine